Patent · US Active

Antigen binding proteins

US10344088B2 · kind B2 · utility

0Cited by
10References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 13, 2014
Grant dateJul 9, 2019
Priority date—
Expiry dateJun 21, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This application discloses antigen binding proteins that bind Lymphocyte Activation Gene 3 (LAG-3), and more particularly to antigen binding proteins that cause depletion of LAG-3+ activated T cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.